Home
Market Capitalization of Brooks Laboratories Ltd

Brooks Laboratories Ltd
NSE: BROOKS
Market Cap
Key Highlights
- The Market Cap of Brooks Laboratories Ltd is ₹ 414.46 crore as of 17 Apr 25 .
- The Latest Trading Price of Brooks Laboratories Ltd is ₹ 140.7 as of 17 Apr 15:30 .

Brooks Laboratories Ltd
NSE: BROOKS
Share Price
Market Price of Brooks Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 140.7 |
16 Apr 2025 | 141.85 |
15 Apr 2025 | 138.75 |
11 Apr 2025 | 132.4 |
09 Apr 2025 | 123.1 |
08 Apr 2025 | 123.5 |
07 Apr 2025 | 113.25 |
04 Apr 2025 | 117.95 |
03 Apr 2025 | 126.8 |
02 Apr 2025 | 129 |
SWOT Analysis Of Brooks Laboratories Ltd
BlinkX Score for Brooks Laboratories Ltd
Asset Value vs Market Value of Brooks Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Brooks Laboratories Ltd
Historical P/E Ratio of Brooks Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Brooks Laboratories Ltd
Historical Revenue of Brooks Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Brooks Laboratories Ltd
Historical EBITDA of Brooks Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Brooks Laboratories Ltd
Historical Net Profit of Brooks Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Brooks Laboratories Ltd
Dividend Payout Over Time
About Brooks Laboratories Ltd
- Brooks Laboratories Limited was incorporated on January 23, 2002.
- The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis.
- The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat.
- Both the units are cGMP compliant in conformity with national and international standards.
- The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.
Brooks Laboratories Ltd News Hub
Brooks Laboratories reports consolidated net loss of Rs 2.41 crore in the June 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 2.41 crore in the quarter ended June 2024 as against
Read more
16 Aug 24
Brooks Laboratories schedules board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2024.
Read more
09 Aug 24
Brooks Laboratories to conduct AGM
Brooks Laboratories announced that the 22th Annual General Meeting (AGM) of the company will be held
Read more
03 Sept 24
Brooks Laboratories to hold AGM
Brooks Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 1
Read more
03 Sept 24